Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Scientists Discover Allergy-Triggering Role of Peptide in the Gut

    Dec 18, 2025, 01:01 AM by User Not Found
    Bio-IT World | It has been firmly established in recent years that regulation of the intestinal epithelium relies heavily on signaling from epithelial, stromal, and immune cells. But there’s also a fourth player, a “very important peptide” known as VIP, which acts directly on stem cells in the gut to restrain an allergy-like response, according to Manuel Jakob, M.D., a clinician-scientist and abdominal surgeon based in Bern, Switzerland and a Ph.D. candidate at Charité -- Universitätsmedizin Berlin.
    Full story
  • Biopharma PEG Expands End-to-End PEGylated Protein Development Services

    Dec 17, 2025, 08:59 AM by
    Biopharma PEG announced the expansion of its professional PEGylated protein development services, offering integrated, end-to-end solutions from recombinant protein expression to high-purity PEG conjugation and comprehensive analytical characterization.
    Full story
  • Caris Life Sciences, Genentech Announce Oncology Collaboration Worth $1.1 Billion

    Dec 17, 2025, 01:01 AM by User Not Found
    Bio-IT World | Caris Life Sciences yesterday announced that its therapeutic research arm, Caris Discovery, has entered into a multi-year collaboration and license agreement with Genentech, a member of the Roche Group.
    Full story
  • Protein Signature Linked to Death Risk Could Aid Life Extension Efforts

    Dec 16, 2025, 10:08 AM by User Not Found
    Bio-IT World | A biological signal of death can be found in the blood five to 10 years in advance of that mortality outcome, a fascinating and unexpected discovery made in the quest for a signature marker of multi-morbidity by researchers at the University of Surry (UK). While by no means a clinically validated predictive test, the protein panels hold promise in motivating lifestyle changes and food choices that could change that poor health trajectory.
    Full story
  • Sanome announces two UK hospital partnerships to deploy AI-powered clinical intelligence for earlier infection detection

    Dec 16, 2025, 09:33 AM by
    Full story
  • Neupulse launches first-of-its-kind wearable with the support of Ensera Design to help people living with Tourette Syndrome

    Dec 16, 2025, 09:33 AM by
    Full story
  • AI unlocks unparalleled efficiency gains in Flare™ V11, Cresset’s leading software solution for digital molecular discovery

    Dec 15, 2025, 09:10 AM by
    Flare V11 features AI generative chemistry technology, enabling researchers to generate new, diverse, drug-like molecules, while new AI Assistants unlock efficiency gains in the user experience and automate the creation of custom workflows.
    Full story
  • CluePoints Scoops Prestigious 2025 Scrip Award

    Dec 15, 2025, 09:10 AM by
    CluePoints, provider of leading statistical and AI-driven software solutions, has won the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 Scrip Awards.
    Full story
  • eClinical Solutions Unveils AI Agents to Power the Next Era of Clinical Data Automation

    Dec 15, 2025, 09:10 AM by
    Built directly into the elluminate ecosystem, the agents combine governed data with explainable intelligence to accelerate decisions
    Full story
  • Modeling and Shared Compute Reveals Pathways of Synthetic Drug

    Dec 12, 2025, 01:01 AM by User Not Found
    Bio-IT World | Researchers from the University of Illinois Urbana-Champaign used deep learning and large-scale computer simulations to identify structural differences in synthetic cannabinoid molecules that cause them to bind to human brain receptors differently from classical cannabinoids.
    Full story
  • 4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology

    Dec 11, 2025, 10:09 AM by
    4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials. Using AMD EPYC™ CPUs on Oracle Cloud Infrastructure (OCI), 4D Path’s QPOR™ platform—a physics-informed, AI-driven, deterministic software engine—can convert routine biopsy images into interpretable biomarkers of tumor and immune response faster and at lower cost.
    Full story
  • Rethinking Precision Oncology in the Age of Functional Data

    Dec 11, 2025, 09:22 AM by User Not Found
    Bio-IT World | Historically, cancer treatment has relied on a one-size-fits-all approach known as the Standard of Care, where patients are treated based on population averages. But cancer is not a single disease; it’s thousands of distinct conditions, each driven by unique biology.
    Full story
  • From Research to Measurable Patient Outcomes, Bio-IT World Conference & Expo Celebrates 25th Annual Event Advancing the Future of Precision Medicine

    Dec 10, 2025, 09:25 AM by
    Bio-IT World Conference & Expo, the premier global event uniting more than 2,900 biopharma, biomedical research, healthcare, informatics and technology leaders, returns to Boston May 19-21, 2026 to celebrate its 25th annual program with a direct impact on the future of precision medicine.
    Full story
  • Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business Officer

    Dec 10, 2025, 09:25 AM by
    Ansa Biotechnologies announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer.
    Full story
  • New York Gastroenterology Associates Taps Proscia for Digital Pathology

    Dec 10, 2025, 09:25 AM by
    New York Gastroenterology Associates, LLP , New York City’s leading independent gastroenterology practice, is working with Proscia®, a pathology AI company, to advance its standard of excellence.
    Full story
  • Advarra expands study collaboration solution, connecting leading clinical trial technology partners to simplify site access

    Dec 10, 2025, 09:25 AM by
    New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra's connected ecosystem, giving sponsors, CROs, and research sites secure, centralized access to critical study technologies
    Full story
  • Oxford Nanopore's Newly Named CEO Brings Diagnostics Expertise

    Dec 8, 2025, 10:02 AM by User Not Found
    Bio-IT World | Oxford Nanopore Technologies named a new CEO this morning, choosing an executive with extensive diagnostics experience. Francis Van Parys, currently CEO of Radiometer, will join Oxford Nanopore and the Board as an Executive Director on March 2, 2026.
    Full story
  • Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers Publish Groundbreaking Study with 1,364 Whole-Genomes of Breast Cancer in Nature

    Dec 8, 2025, 08:10 AM by
    Landmark study from Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers explores the whole genomes of 1,364 breast cancers, uncovering predictive biomarkers that link genomic signatures to potential treatment outcomes and support advancing precision oncology.
    Full story
  • Lab Thread Announces Beta Release of Unified Lab Software Platform

    Dec 8, 2025, 08:10 AM by
    Silverstone, UK, 8 December 2025: Lab Thread Ltd, a UK‐based life science software company, today announced the beta launch of its flagship unified lab software platform. Lab Thread is uniquely designed to provide an intuitive and adoptable platform with powerful collaborative features – helping to unite researchers, lab operations and scientific data from across diverse teams and advance scientific discovery.
    Full story
  • Quotient Sciences and Intrepid Labs form strategic partnership to accelerate AI-guided formulation development

    Dec 5, 2025, 09:12 AM by
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy